Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Time trends in the incidence and survival of vaginal squamous cell carcinoma and high-grade vaginal intraepithelial neoplasia in Denmark - A nationwide population-based study

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Incidence of vulvar high-grade precancerous lesions and cancer in Denmark before and after introduction of HPV vaccination

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Non-epithelial ovarian cancer in Denmark - Incidence and survival over nearly 40 years

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Risk of endometrial cancer among women with benign ovarian tumors - A Danish nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Human papillomavirus genotype-specific risks for cervical intraepithelial lesions

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Borderline ovarian tumors in Denmark 1997-2018: Time trends in incidence by histology, age and educational level

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Low-dose aspirin use and risk of head and neck cancer-A Danish nationwide case-control study

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Endometrial cancer risk after fertility treatment: a population-based cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  • Hanna Kristina Bertoli
  • Louise Baandrup
  • Gitte Lerche Aalborg
  • Alexander K Kjaer
  • Louise T Thomsen
  • Susanne K Kjaer
View graph of relations

Objective: To describe trends in incidence of high-grade vaginal intraepithelial neoplasia (VaIN) and vaginal squamous cell carcinoma (SCC) in Denmark. For vaginal SCC, we also examine 5-year relative survival and mortality. Methods: All high-grade VaIN cases diagnosed 1997–2017 and vaginal SCCs during 1978–2017 were identified in two high-quality nationwide registers. Age-standardized incidence rates and average annual percentage change (AAPC) were assessed. For vaginal SCC, 5-year relative survival was calculated, and Cox regression was applied to study the effect of selected characteristics on mortality. Results: Altogether, 831 cases of high-grade VaIN and 721 vaginal SCCs were identified. The age-standardized incidence rate of high-grade VaIN showed no clear trend over time. However, when we stratified by age and divided the study period according to HPV vaccine licensure in Denmark (2006), the incidence of high-grade VaIN decreased significantly by 15.6% per year (95% CI: −23.2, −7.3%) after 2007 onwards among the youngest women (<30 years). For vaginal SCC, the incidence decreased from 0.5 (1978–1982) to 0.3 (2013–2017) per 100,000 woman-years. The 5-year relative survival improved over time and was 67.9% (95% CI: 54.9, 84.1%) in the most recent time period. Mortality was significantly associated with calendar year, age, and stage at diagnosis. Conclusions: The overall incidence of high-grade VaIN showed no clear trend over time, but a significant decline was observed in women younger than 30 years after HPV vaccine licensure. The incidence of vaginal SCC was reduced by approximately 50% and survival after vaginal SCC improved over time.

Original languageEnglish
JournalGynecologic Oncology
Volume158
Issue number3
Pages (from-to)734-739
Number of pages6
ISSN0090-8258
DOIs
Publication statusPublished - 1 Sep 2020

    Research areas

  • Incidence, Relative survival, Vaginal cancer, VaIN

ID: 61556412